Krilogy Financial’s Vanda Pharmaceuticals VNDA Stock Holding History

Krilogy Financial’s Portfolio VNDA Stock Details VNDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$99.8K	Buy	+16,308	New	+$107K	﹤0.01%	1009
2018 Q4	–	Sell	-100	Closed	-$2K	–	662
2018 Q3	$2K	Buy	+100	New	+$2.04K	﹤0.01%	749
2017 Q3	–	Sell	-200	Closed	-$3K	–	848
2017 Q2	$3K	Hold	200	–	–	﹤0.01%	649
2017 Q1	$3K	Hold	200	–	–	﹤0.01%	635
2016 Q4	$3K	Buy	200 +100	+100%	+$1.61K	﹤0.01%	635
2016 Q3	$2K	Sell	100 -200	-67%	-$2.69K	﹤0.01%	677
2016 Q2	$3K	Hold	300	–	–	﹤0.01%	665
2016 Q1	$3K	Buy	+300	New	+$2.46K	﹤0.01%	589
2015 Q4	–	Sell	-300	Closed	-$3K	–	602
2015 Q3	$3K	Buy	+300	New	+$3.67K	﹤0.01%	524

Other funds holding VNDA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Krilogy Financial's VNDA Position: Q2 2026 in Review

Krilogy Financial opened a new position in Vanda Pharmaceuticals (VNDA) in Q2 2026: 16,308 shares worth $99.8K. The stake represents ﹤0.01% of the portfolio and ranks #1009 among its holdings. This is a return to the name: Krilogy Financial previously reported a position in VNDA as recently as Q3 2018.

Krilogy Financial first reported a position in VNDA in Q3 2015 and has held it in 9 quarters since. 173 funds tracked by Wall St. Rank hold VNDA as of Q2 2026.

Krilogy Financial held 16,308 shares of Vanda Pharmaceuticals worth $99.8K as of Q2 2026.
Vanda Pharmaceuticals was a new Krilogy Financial position in Q2 2026.
Vanda Pharmaceuticals made up ﹤0.01% of Krilogy Financial's portfolio in Q2 2026, its #1009 holding.
Krilogy Financial first reported a position in Vanda Pharmaceuticals in Q3 2015 and has held it in 9 quarters since.
173 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2026.

Based on Krilogy Financial's 13F filing for Q2 2026, filed 27 Jul 2026.